| LATEST NEWS | AXIS REIT targets total acquisition value of RM300 million this year - CEO | The ringgit is likely to trade sideways, with an end-of-year forecast of RM4.45 against the US dollar - AmBank chief economist | BNM will maintain its accommodative stance and keep the OPR steady through at least 1H2025 - AmBank chief economist | Malaysia’s GDP growth is expected to moderate to 4.6 pct in 2025, supported by infrastructure projects, private investment realisations and strong private consumption - AmBank chief economist | The KLIA aerotrain is set to resume in Q2, with no impact on Malaysia's ASEAN chairmanship - MAHB Managing Director | |
KUALA LUMPUR, Oct 2 (Bernama) -- Sunzen Biotech Bhd’s acquisition of 70 per cent equity interest in Eye Nation Medical Sdn Bhd, a company engaged in the optical medical diagnostic equipment business, will allow the group to expand into the ophthalmic industry.
